Dr. Beulah Elizabeth Koshy DNB,MRCP*,DM (Med.Oncology)

• Medical Oncologist with a completed DM (Doctorate of Medicine) in Medical Oncology, and formal postgraduate training in Internal Medicine (DNB Internal Medicine; MRCP (UK)).
• Possesses structured clinical exposure to both solid and haematological malignancies at a tertiary cancer centre, with active involvement in clinical research and real-world evidence generation.
• Winner of the International ASCO IDEA Award-Alternate(2026) and the National LEAP 2.0 Award (2025).
• Professional interests include integrated oncology–palliative care, symptom management, supportive care during systemic therapy, optimisation of treatment tolerance, and enhancement of quality of life for patients with advanced malignancies, particularly within resource-constrained healthcare settings.

• Basic Life Support (BLS)
• Advanced Cardiovascular Life Support (ACLS)

• ASCO IDEA Award (2026)-Alternate; American Society of Clinical Oncology
• LEAP 2.0 (2025); Roche

1. Koshy BE, Jacob LA, et al. A Retrospective Study on the Use of Short-Term Combination Pharmacotherapy in Improving Weight, Appetite and Tolerance to Cytotoxic Chemotherapy in Locally Advanced Solid Cancers. Medical Research Archives. 2025;13(5). https://doi.org/10.18103/mra.v13i5.6545

2. Koshy BE, Jacob LA, et al. Patient Characteristics, Treatment Patterns, and Survival Outcomes in Newly Diagnosed Multiple Myeloma: A Single-Center Study from South India. Medical Research Archives. 2025;13(5). https://doi.org/10.18103/mra.v13i5.6593

3. Jacob LA, Koshy BE, et al. Beyond Guidelines: Real World Treatment & Outcomes of Chronic Lymphocytic Leukemia at a Tertiary Indian Cancer Centre. Medical Research Archives. 2025;13(5). https://doi.org/10.18103/mra.v13i5.6529

4. Nagendrappa LK, Shankaranarayana AN, Koshy BE, et al. Intrathecal Trastuzumab as a Novel Simplified Therapeutic Strategy for Isolated Metastases in the Leptomeninges in HER2-Positive Breast Cancer: A Case Report and Review of Literature. Indian Journal of Medical and Paediatric Oncology. 2025. https://doi.org/10.1055/s-0045-1809447

5. Saldanha SC, Babu S, Patil A, Lokesh KN, Rudresha DM AH, Rajeev LK, Patidar Y, Koshy B, Kiran PR, Jacob LA. Clinical Characteristics and Treatment Response in Double-Expressor vs Double-/Triple-Hit DLBCL: A Prospective Study in a Tertiary Care Center in South India. Clinical Lymphoma Myeloma and Leukemia. 2025;25:S774-5. https://doi.org/10.1016/S2152-2650(25)02331-6

6. RajeecvLK,AnandhaNS,KoshyBE,SureshB,LokeshKN,RudreshaAH,SmithaS.TheClinical Challenge of Maxillary Osteosarcoma – A Case Report with Review of Literature. International Journal of Scientific Research. 2025;14(5): 3-4 https://doi.org/10.36106/ijsr/0300272

7. Saldhana SC, Ananda NS, Sunil C, Koshy BE, Suresh B et al. A Prospective Non-Randomized Observational Study assessing efficacy of Netupitant and Palonosetron (NEPA) Versus Fosaprepitant and Palonosetron for Chemotherapy Induced Nausea and Vomiting Prevention in AutologousStemCellTransplantationinSouthIndia.MedicalResearchArchives.

2025;13(9).https://doi.org/10.18103/mra.v13i9.7005.

1) "Prognostic Value of Interim PET-CT in Diffuse Large B-Cell Lymphoma": Evaluation of interim PET-CT as a predictor of treatment response and long-term outcomes to optimise therapy and reduce overtreatment in Indian patients.

2) "Prognostic Value of FLT3 Mutations in Acute Promyelocytic Leukemia (APML)": Assessment of the impact of FLT3 mutations on relapse risk and survival to refine risk stratification in resource-limited settings.

• Integrated oncology–palliative care
• Symptom management
• Supportive care during systemic therapy
• Optimisation of treatment tolerance
• Enhancement of quality of life for patients with advanced malignancies

• American Society of Clinical Oncology (ASCO)
• European Society for Medical Oncology (ESMO)
• Indian Society of Medical and Paediatric Oncology (ISMPO)
• Association of Medical Oncologists of India (AMOI)

MRCP Internal Medicine - Part 1 and 2 (Written)-cleared

*MRCP Internal Medicine PACES -pending